Welcome to our dedicated page for Thermo Fishr Sci news (Ticker: TMO), a resource for investors and traders seeking the latest updates and insights on Thermo Fishr Sci stock.
Thermo Fisher Scientific reports news across scientific instruments, laboratory equipment, diagnostics consumables, life science reagents and pharmaceutical services. Company updates commonly cover operating results, earnings calls, investor presentations and capital deployment through dividends, share repurchases and acquisitions.
Recurring developments also include collaborations tied to laboratory technologies, proteomics, biobank research, analytical instruments and biopharma customer services. Thermo Fisher’s brand portfolio includes Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD, and its completed Clario acquisition added endpoint data solutions for clinical trials to its Laboratory Products and Biopharma Services segment.
Thermo Fisher Scientific (NYSE: TMO) has introduced the Thermo Scientific Stellar mass spectrometer (MS), a pioneering tool designed to enhance clinical research and precision medicine. The Stellar MS offers fast throughput, high sensitivity, and ease of use, significantly advancing translational omics research. This new tool complements the Thermo Scientific Orbitrap Astral MS by verifying key biomarkers, including peptides, metabolites, and lipids. Featuring third-party software support and integration with the Thermo Scientific Vanquish Neo UHPLC system, the Stellar MS delivers 10X quantitative sensitivity, enabling researchers to analyze five times more compounds and complete studies faster. Thermo Fisher will showcase the Stellar MS at the ASMS annual conference in June 2024.
Thermo Fisher Scientific released its 2023 Corporate Social Responsibility (CSR) report, detailing the company's commitments and progress in various areas. The report highlights the company's efforts in community support, environmental sustainability, and workforce development. Thermo Fisher employees volunteered over 100,000 hours globally and engaged more than 60,000 students in STEM competitions. The company is committed to achieving net-zero emissions by 2050, utilizing 41% renewable energy, and aims for 80% renewable electricity by 2030. Workforce initiatives include new training programs and enhanced wellness resources.
Thermo Fisher Scientific (NYSE: TMO), a leading entity in the science sector, has declared a quarterly cash dividend of $0.39 per common share.
This dividend is scheduled for payment on July 15, 2024, to shareholders recorded by June 14, 2024.
Thermo Fisher Scientific Inc. (NYSE: TMO) will have its chairman, president, and CEO present at the BofA Securities Health Care Conference on May 14, 2024. The live webcast will be available on the company's website.
Thermo Fisher Scientific, a global leader in scientific services, extends the expiration of the tender offer for all outstanding common shares and ADSs of Olink. The offer, scheduled to expire on June 18, 2024, aims to acquire Olink Holding AB for $26.00 per share in cash. As of April 30, 2024, approximately 94.3% of outstanding shares have been tendered. Completion of the offer is subject to regulatory approval.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.